Keywords: Clinical Research, Cognitive Systems, Diagnosis, Diffusion In Liquids, Magnetic Resonance Imaging, Molecules, Neurodegenerative Diseases, Positron Emission Tomography, Differential Diagnosis, Diffusion-Weighted Mri, Functional Activation, Magnetic Resonance Imaging (mri), Multiple System Atrophies, Positron Emission Tomography (pet), Research Applications, Subcortical Structures, Functional Neuroimaging
Affiliations: *** IBB - CNR ***
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Biostructure and Bioimaging Institute, National Research Council, Naples, Italy
References: Braak, H., Bohl, J.R., Muller, C.M., Rub, U., De Vos, R.A., Del Tredici, K., Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered (2006) Mov Disord, 21 (12), pp. 2042-205
Goedert, M., Spillantini, M.G., Del Tredici, K., Braak, H., 100 years of Lewy pathology (2013) Nat Rev Neurol, 9 (1), pp. 13-24. , nrneurol.2012.242 [pii]
Shah, M., Seibyl, J., Cartier, A., Bhatt, R., Catafau, A.M., Molecular imaging insights into neurodegeneration: Focus on alpha-synuclein radiotracers (2014) J Nucl Med, 55 (9), pp. 1397-1400
Jellinger, K.A., Seppi, K., Wenning, G.K., Grading of neuropathology in multiple system atrophy: Proposal for a novel scale (2005) Mov Disord, 20, pp. S29-S36
Williams, D.R., Holton, J.L., Strand, C., Pittman, A., De Silva, R., Lees, A.J., Revesz, T., Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome (2007) Brain, 130, pp. 1566-1576. , [pii]
Yoshida, M., Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration (2014) Neuropathology, 34 (6), pp. 555-570
Dickson, D.W., Neuropathologic differentiation of progressive supranuclear palsy and cortico-basal degeneration (1999) J Neurol, 246, pp. II6-II15. , [pii]
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.R., Higuchi, M., Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls (2013) Neuron, 79 (6), pp. 1094-1108
Kepe, V., Bordelon, Y., Boxer, A., Huang, S.C., Liu, J., Thiede, F.C., Mazziotta, J.C., Barrio, J.R., PET imaging of neuropathology in tauopathies: Progressive supranuclear palsy (2013) J Alzheimers Dis, 36 (1), pp. 145-153
Snow, B.J., Tooyama, I., Mc Geer, E.G., Yamada, T., Calne, D.B., Takahashi, H., Kimura, H., Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels (1993) Ann Neurol, 34 (3), pp. 324-330
Burn, D.J., Sawle, G.V., Brooks, D.J., Differential diagnosis of Parkinson’s disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal 18F-dopa PET data (1994) J Neurol Neurosurg Psychiatry, 57 (3), pp. 278-284
Sawle, G.V., Playford, E.D., Burn, D.J., Cunningham, V.J., Brooks, D.J., Separating Parkinson’s disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data (1994) Arch Neurol, 51 (3), pp. 237-243
Rinne, J.O., Laihinen, A., Nagren, K., Ruottinen, H., Ruotsalainen, U., Rinne, U.K., PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson’s disease (1995) Synapse, 21 (2), pp. 97-103
Frey, K.A., Koeppe, R.A., Kilbourn, M.R., Vander Borght, T.M., Albin, R.L., Gilman, S., Kuhl, D.E., Presynaptic monoaminergic vesicles in Parkinson’s disease and normal aging (1996) Ann Neurol, 40 (6), pp. 873-884
Kazumata, K., Dhawan, V., Chaly, T., Antonini, A., Margouleff, C., Belakhlef, A., Neumeyer, J., Eidelberg, D., Dopamine transporter imaging with fluorine-18-FPCIT and PET (1998) J Nucl Med, 39 (9), pp. 1521-1530
Rinne, J.O., Ruottinen, H., Bergman, J., Haaparanta, M., Sonninen, P., Solin, O., Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson’s disease (1999) J Neurol Neurosurg Psychiatry, 67 (6), pp. 737-741
Lee, C.S., Samii, A., Sossi, V., Ruth, T.J., Schulzer, M., Holden, J.E., Wudel, J., Stoessl, A.J., In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease (2000) Ann Neurol, 47 (4), pp. 493-503
Martin, W.R., Wieler, M., Stoessl, A.J., Schulzer, M., Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson’s disease (2008) Ann Neurol, 63 (3), pp. 388-394
Cumming, P., PET studies of DOPA utilization (2009) Imaging Dopamine, pp. 54-79. , Cumming P, 1st edn. Cambridge University Press, Cambridge
Okamura, N., Villemagne, V.L., Drago, J., Pejoska, S., Dhamija, R.K., Mulligan, R.S., Ellis, J.R., Rowe, C.C., In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133 (2010) J Nucl Med, 51 (2), pp. 223-228. , jnumed.109.070094 [pii]
Gallagher, C.L., Oakes, T.R., Johnson, S.C., Chung, M.K., Holden, J.E., Bendlin, B.B., Mc Laren, D.G., Brown, W.D., Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson’s disease (2011) Mov Disord, 26 (4), pp. 614-620
Fazio, P., Svenningsson, P., Forsberg, A., Jonsson, E.G., Amini, N., Nakao, R., Nag, S., Varrone, A., Quantitative analysis of (1)(8)F-(E)-N-(3-iodoprop-2-enyl)-2beta-carbofluoroethoxy-3beta-(4'-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease (2015) J Nucl Med, 56 (5), pp. 714-720. , jnumed.114.152421 [pii]
Jellinger, K.A., Post mortem studies in Parkinson’s disease - is it possible to detect brain areas for specific symptoms? (1999) J Neural Transm, 56, pp. 1-29
Morrish, P.K., Sawle, G.V., Brooks, D.J., The rate of progression of Parkinson’s disease. A longitudinal [18F]DOPA PET study (1996) Adv Neurol, 69, pp. 427-431
Morrish, P.K., Rakshi, J.S., Bailey, D.L., Sawle, G.V., Brooks, D.J., Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET (1998) J Neurol Neurosurg Psychiatry, 64 (3), pp. 314-319
Nurmi, E., Ruottinen, H.M., Kaasinen, V., Bergman, J., Haaparanta, M., Solin, O., Rinne, J.O., Progression in Parkinson’s disease: A positron emission tomography study with a dopamine transporter ligand [18F] CFT (2000) Ann Neurol, 47 (6), pp. 804-808
Brooks, D.J., Frey, K.A., Marek, K.L., Oakes, D., Paty, D., Prentice, R., Shults, C.W., Stoessl, A.J., Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson’s disease (2003) Exp Neurol, 184, pp. S68-S79
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C.S., Mc Kenzie, J., Stoessl, A.J., Longitudinal progression of sporadic Parkinson’s disease: A multi-tracer positron emission tomography study (2009) Brain, 132, pp. 2970-2979
Brooks, D.J., Piccini, P., Maging in Parkinson’s disease: The role of monoamines in behavior (2006) Biol Psychiatry, 59 (10), pp. 908-918. , 12.017, S0006-3223(06)00187-9 [pii]
Menza, M.A., Mark, M.H., Burn, D.J., Brooks, D.J., Personality correlates of [18F]dopa striatal uptake: Results of positron-emission tomography in Parkinson’s disease (1995) J Neuropsychiatry Clin Neurosci, 7 (2), pp. 176-179
Kaasinen, V., Nurmi, E., Bergman, J., Eskola, O., Solin, O., Sonninen, P., Rinne, J.O., Personality traits and brain dopaminergic function in Parkinson’s disease (2001) Proc Natl Acad Sci US A, 98 (23), pp. 13272-13277. , [pii]
Gill, S.S., Patel, N.K., Hotton, G.R., O’sullivan, K., Mc Carter, R., Bunnage, M., Brooks, D.J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat Med, 9 (5), pp. 589-595
Paul, G., Zachrisson, O., Varrone, A., Almqvist, P., Jerling, M., Lind, G., Rehncrona, S., Haegerstrand, A., Safety and tolerability of intracerebroven-tricular PDGF-BB in Parkinson’s disease patients (2015) J Clin Invest, 125 (3), pp. 1339-1346. , 79635 [pii]
Antonini, A., Schwarz, J., Oertel, W.H., Pogarell, O., Leenders, K.L., Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: A study with positron emission tomography and [11C]raclopride (1997) Mov Disord, 12 (1), pp. 33-38
Brooks, D.J., Ibanez, V., Sawle, G.V., Playford, E.D., Quinn, N., Mathias, C.J., Lees, A.J., Frackowiak, R.S., Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography (1992) Ann Neurol, 31 (2), pp. 184-192
Antonini, A., Leenders, K.L., Vontobel, P., Maguire, R.P., Missimer, J., Psylla, M., Gunther, I., Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson’s disease (1997) Brain, 120, pp. 2187-2195
Ghaemi, M., Hilker, R., Rudolf, J., Sobesky, J., Heiss, W.D., Differentiating multiple system atrophy from Parkinson’s disease: Contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging (2002) J Neurol Neurosurg Psychiatry, 73 (5), pp. 517-523
Van Laere, K., Clerinx, K., D’hondt, E., De Groot, T., Vandenberghe, W., Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease J Nucl Med, 51 (4), pp. 588-595. , jnumed.109.070144 [pii]
Grunder, G., Siessmeier, T., Piel, M., Vernaleken, I., Buchholz, H.G., Zhou, Y., Hiemke, C., Bartenstein, P., Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride (2003) J Nucl Med, 44 (1), pp. 109-116
La Fougere, C., Popperl, G., Levin, J., Wangler, B., Boning, G., Uebleis, C., Cumming, P., Tatsch, K., The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes (2010) J Nucl Med, 51 (4), pp. 581-587. , jnumed.109.071811 [pii]
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M.F., Feigin, A.S., Eidelberg, D., FDG PET in the differential diagnosis of parkinsonian disorders (2005) Neuroimage, 26 (3), pp. 912-921. , S1053-8119(05)00152-7 [pii]
Guttman, M., Boileau, I., Warsh, J., Saint-Cyr, J.A., Ginovart, N., Mc Cluskey, T., Houle, S., Kish, S.J., Brain serotonin transporter binding in nondepressed patients with Parkinson’s disease (2007) Eur J Neurol, 14 (5), pp. 523-528. , ENE1727 [pii]
Albin, R.L., Koeppe, R.A., Bohnen, N.I., Wernette, K., Kilbourn, M.A., Frey, K.A., Spared caudal brainstem SERT binding in early Parkinson’s disease (2008) J Cereb Blood Flow Metab, 28 (3), pp. 441-444. , 9600599 [pii]
Politis, M., Wu, K., Loane, C., Kiferle, L., Molloy, S., Brooks, D.J., Piccini, P., Staging of serotonergic dysfunction in Parkinson’s disease: An in vivo 11C-DASB PET study (2010) Neurobiol Dis, 40 (1), pp. 216-221. , S0969-9961(10)00190-7 [pii]
Doder, M., Rabiner, E.A., Turjanski, N., Lees, A.J., Brooks, D.J., Tremor in Parkinson’s disease and serotonergic dysfunction: An 11C-WAY 100635 PET study (2003) Neurology, 60 (4), pp. 601-605
Ballanger, B., Klinger, H., Eche, J., Lerond, J., Vallet, A.E., Le Bars, D., Tremblay, L., Thobois, S., Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson’s disease (2012) Mov Disord, 27 (1), pp. 84-89
Varrone, A., Svenningsson, P., Forsberg, A., Varnas, K., Tiger, M., Nakao, R., Halldin, C., Farde, L., Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson’s disease (2014) Neurobiol Aging, 35 (4), pp. 867-875. , S0197-4580(13)00370-9 [pii]
Pavese, N., Metta, V., Bose, S.K., Chaudhuri, K.R., Brooks, D.J., Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction (2010) Brain, 133 (11), pp. 3434-3443. , awq268 [pii]
Remy, P., Doder, M., Lees, A., Turjanski, N., Brooks, D., Depression in Parkinson’s disease: Loss of dopamine and noradrenaline innervation in the limbic system (2005) Brain, 128, pp. 1314-1322. , awh445 [pii]
Shinotoh, H., Namba, H., Yamaguchi, M., Fukushi, K., Nagatsuka, S., Iyo, M., Asahina, M., Irie, T., Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson’s disease and progressive supranuclear palsy (1999) Ann Neurol, 46 (1), pp. 62-69
Niccolini, F., Foltynie, T., Reis Marques, T., Muhlert, N., Tziortzi, A.C., Searle, G.E., Natesan, S., Politis, M., Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease (2015) Brain, , awv219 [pii]
Foster, N.L., Minoshima, S., Johanns, J., Little, R., Heumann, M.L., Kuhl, D.E., Gilman, S., PET measures of benzodiazepine receptors in progressive supranuclear palsy (2000) Neurology, 54 (9), pp. 1768-1773
Brenneis, C., Seppi, K., Schocke, M., Benke, T., Wenning, G.K., Poewe, W., Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy (2004) J Neurol Neurosurg Psychiatry, 75 (2), pp. 246-249
Fukuda, M., Edwards, C., Eidelberg, D., Functional brain networks in Parkinson’s disease (2001) Parkinsonism Relat Disord, 8 (2), pp. 91-94. , [pii]
Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M., Dhawan, V., Eidelberg, D., Changes in network activity with the progression of Parkinson’s disease (2007) Brain, 130, pp. 1834-1846. , awm086 [pii]
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Nagren, K., Darcourt, J., Van Laere, K., EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 (2009) Eur J Nucl Med Mol Imaging, 36 (12), pp. 2103-2110
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Brooks, D.J., In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease (2006) Neurobiol Dis, 21 (2), pp. 404-412. , S0969-9961(05)00226-3 [pii]
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., Torizuka, T., Microglial activation and dopamine terminal loss in early Parkinson’s disease (2005) Ann Neurol, 57 (2), pp. 168-175
Gerhard, A., Banati, R.B., Goerres, G.B., Cagnin, A., Myers, R., Gunn, R.N., Turkheimer, F., Brooks, D.J., [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy (2003) Neurology, 61 (5), pp. 686-689
Gerhard, A., Trender-Gerhard, I., Turkheimer, F., Quinn, N.P., Bhatia, K.P., Brooks, D.J., In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy (2006) Mov Disord, 21 (1), pp. 89-93
Kobylecki, C., Counsell, S.J., Cabanel, N., Wachter, T., Turkheimer, F.E., Eggert, K., Oertel, W., Gerhard, A., Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes (2013) Parkinsonism Relat Disord, 19 (5), pp. 527-532. , S1353-8020(13)00052-7 [pii]
Dodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Eggert, K., Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial) (2010) Mov Disord, 25 (1), pp. 97-107
Jucaite, A., Svenningsson, P., Rinne, J.O., Cselenyi, Z., Varnas, K., Johnstrom, P., Amini, N., Farde, L., Effect of the myeloperoxidase inhibitor AZD3241 on microglia: A PET study in Parkinson’s disease (2015) Brain, 138, pp. 2687-2700. , awv184 [pii]
(2006) Parkinson’s Disease: Diagnosis and Management in Primary and Secondary Care, pp. NICE. , http://www.nice.org.uk/guidance/cg35/resources/guidance-parkinsons-disease-pdf, Accessed 4 Apr 2015
Massey, L.A., Micallef, C., Paviour, D.C., O’sullivan, S.S., Ling, H., Williams, D.R., Kallis, C., Jager, H.R., Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy (2012) Mov Disord, 27 (14), pp. 1754-1762
Tolosa, E., Wenning, G., Poewe, W., The diagnosis of Parkinson’s disease (2006) Lancet Neurol, 5 (1), pp. 75-86
Kato, N., Arai, K., Hattori, T., Study of the rostral midbrain atrophy in progressive supranuclear palsy (2003) J Neurol Sci, 210 (1-2), pp. 57-60
Josephs, K.A., Frontotemporal lobar degeneration (2007) Neurol Clin, 25 (3), pp. 683-696. , vi
Righini, A., Antonini, A., De Notaris, R., Bianchini, E., Meucci, N., Sacilotto, G., Canesi, M., Pezzoli, G., MR imaging of the superior profile of the midbrain: Differential diagnosis between progressive supranuclear palsy and Parkinson disease (2004) AJNR am J Neuroradiol, 25 (6), pp. 927-932
Adachi, M., Kawanami, T., Ohshima, H., Sugai, Y., Hosoya, T., Morning glory sign: A particular MR finding in progressive supranuclear palsy (2004) Magn Reson Med Sci, 3 (3), pp. 125-132
Lee, J.Y., Yun, J.Y., Shin, C.W., Kim, H.J., Jeon, B.S., Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy (2010) J Neurol, 257 (12), pp. 2065-2070
Schwarz, J., Weis, S., Kraft, E., Tatsch, K., Bandmann, O., Mehraein, P., Vogl, T., Oertel, W.H., Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy (1996) J Neurol Neurosurg Psychiatry, 60 (1), pp. 98-101
Lee, W.H., Lee, C.C., Shyu, W.C., Chong, P.N., Lin, S.Z., Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3 T (2005) AJNR am J Neuroradiol, 26 (9), pp. 2238-2242
Tha, K.K., Terae, S., Tsukahara, A., Soma, H., Morita, R., Yabe, I., Ito, Y.M., Shirato, H., Hyperintense putaminal rim at 1.5 T: Prevalence in normal subjects and distinguishing features from multiple system atrophy (2012) BMC Neurol, 12, p. 39
Wenning, G.K., Colosimo, C., Geser, F., Poewe, W., Multiple system atrophy (2004) Lancet Neurol, 3 (2), pp. 93-103
Muqit, M.M., Mort, D., Miskiel, K.A., Shakir, R.A., Hot cross bun sign in a patient with parkinsonism secondary to presumed vasculitis (2001) J Neurol Neurosurg Psychiatry, 71 (4), pp. 565-566
Soares-Fernandes, J.P., Ribeiro, M., Machado, A., Hot cross bun sign in variant Creutzfeldt-Jakob disease (2009) AJNR am J Neuroradiol, 30 (3), pp. E37
Cochrane, C.J., Ebmeier, K.P., Diffusion tensor imaging in parkinsonian syndromes: A systematic review and meta-analysis (2013) Neurology, 80 (9), pp. 857-864
Vaillancourt, D.E., Spraker, M.B., Prodoehl, J., Abraham, I., Corcos, D.M., Zhou, X.J., Comella, C.L., Little, D.M., High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease (2009) Neurology, 72 (16), pp. 1378-1384
Schocke, M.F., Seppi, K., Esterhammer, R., Kremser, C., Jaschke, W., Poewe, W., Wenning, G.K., Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD (2002) Neurology, 58 (4), pp. 575-580
Ito, M., Watanabe, H., Kawai, Y., Atsuta, N., Tanaka, F., Naganawa, S., Fukatsu, H., Sobue, G., Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy (2007) J Neurol Neurosurg Psychiatry, 78 (7), pp. 722-728
Pellecchia, M.T., Barone, P., Vicidomini, C., Mollica, C., Salvatore, E., Ianniciello, M., Liuzzi, R., Pappata, S., Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion-weighted MR study (2011) Mov Disord, 26 (7), pp. 1303-1309
Nicoletti, G., Lodi, R., Condino, F., Tonon, C., Fera, F., Malucelli, E., Manners, D., Quattrone, A., Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy (2006) Brain, 129, pp. 2679-2687
Paviour, D.C., Thornton, J.S., Lees, A.J., Jager, H.R., Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy (2007) Mov Disord, 22 (1), pp. 68-74
Tsukamoto, K., Matsusue, E., Kanasaki, Y., Kakite, S., Fujii, S., Kaminou, T., Ogawa, T., Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson’s disease: Evaluation by 3.0-T MR imaging (2012) Neuroradiology, 54 (9), pp. 947-955
Baudrexel, S., Seifried, C., Penndorf, B., Klein, J.C., Middendorp, M., Steinmetz, H., Grunwald, F., Hilker, R., The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy (2014) Mov Disord, 29 (3), pp. 380-387
Nair, S.R., Tan, L.K., Mohd Ramli, N., Lim, S.Y., Rahmat, K., Mohd Nor, H., A decision tree for differentiating multiple system atrophy from Parkinson’s disease using 3-T MR imaging (2013) Eur Radiol, 23 (6), pp. 1459-1466
Erbetta, A., Mandelli, M.L., Savoiardo, M., Grisoli, M., Bizzi, A., Soliveri, P., Chiapparini, L., Girotti, F., Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration (2009) AJNR am J Neuroradiol, 30 (8), pp. 1482-1487
Whitwell, J.L., Schwarz, C.G., Reid, R.I., Kantarci, K., Jack, C.R., Jr., Josephs, K.A., Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes (2014) Parkinsonism Relat Disord, 20 (5), pp. 493-498
Catani, M., Howard, R.J., Pajevic, S., Jones, D.K., Virtual in vivo interactive dissection of white matter fasciculi in the human brain (2002) Neuroimage, 17 (1), pp. 77-94
Nilsson, C., Markenroth Bloch, K., Brockstedt, S., Latt, J., Widner, H., Larsson, E.M., Tracking the neurodegeneration of parkinsonian disorders - a pilot study (2007) Neuroradiology, 49 (2), pp. 111-119
Surova, Y., Nilsson, M., Latt, J., Lampinen, B., Lindberg, O., Hall, S., Widner, H., Hansson, O., Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy (2015) Neuroradiology
Drayer, B.P., Olanow, W., Burger, P., Johnson, G.A., Herfkens, R., Riederer, S., Parkinson plus syndrome: Diagnosis using high field MR imaging of brain iron (1986) Radiology, 159 (2), pp. 493-498
Haacke, E.M., Mittal, S., Wu, Z., Neelavalli, J., Cheng, Y.C., Susceptibility-weighted imaging: Technical aspects and clinical applications, part 1 (2009) AJNR am J Neuroradiol, 30 (1), pp. 19-30
Du, G., Liu, T., Lewis, M.M., Kong, L., Wang, Y., Connor, J., Mailman, R.B., Huang, X., Quantitative susceptibility mapping of the midbrain in Parkinson’s disease (2015) Mov Disord.
He, N., Ling, H., Ding, B., Huang, J., Zhang, Y., Zhang, Z., Liu, C., Yan, F., Region-specific disturbed iron distribution in early idiopathic Parkinson’s disease measured by quantitative susceptibility mapping (2015) Hum Brain Mapp
Zhang, W., Sun, S.G., Jiang, Y.H., Qiao, X., Sun, X., Wu, Y., Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging (2009) Neurosci Bull, 25 (6), pp. 353-360
Zhang, J., Zhang, Y., Wang, J., Cai, P., Luo, C., Qian, Z., Dai, Y., Feng, H., Characterizing iron deposition in Parkinson’s disease using susceptibility-weighted imaging: An in vivo MR study (2010) Brain Res, 1330, pp. 124-130
Wang, Y., Butros, S.R., Shuai, X., Dai, Y., Chen, C., Liu, M., Haacke, E.M., Xu, H., Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging (2012) AJNR am J Neuroradiol, 33 (2), pp. 266-273
Lotfipour, A.K., Wharton, S., Schwarz, S.T., Gontu, V., Schafer, A., Peters, A.M., Bowtell, R.W., Bajaj, N.P., High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson’s disease (2012) J Magn Reson Imaging, 35 (1), pp. 48-55
Han, Y.H., Lee, J.H., Kang, B.M., Mun, C.W., Baik, S.K., Shin, Y.I., Park, K.H., Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy (2013) J Neurol Sci, 325 (1-2), pp. 29-35
Lee, J.H., Han, Y.H., Kang, B.M., Mun, C.W., Lee, S.J., Baik, S.K., Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy (2013) J Neurol, 260 (8), pp. 2094-2101
Gupta, D., Saini, J., Kesavadas, C., Sarma, P.S., Kishore, A., Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism (2010) Neuroradiology, 52 (12), pp. 1087-1094
Cho, Z.H., Oh, S.H., Kim, J.M., Park, S.Y., Kwon, D.H., Jeong, H.J., Kim, Y.B., Jeon, B.S., Direct visualization of Parkinson’s disease by in vivo human brain imaging using 7.0 T magnetic resonance imaging (2011) Mov Disord, 26 (4), pp. 713-718
Lehericy, S., Bardinet, E., Poupon, C., Vidailhet, M., Francois, C., 7 Tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson’s disease (2014) Mov Disord, 29 (13), pp. 1574-1581
Noh, Y., Sung, Y.H., Lee, J., Kim, E.Y., Nigrosome 1 detection at 3 T MRI for the diagnosis of early-stage idiopathic Parkinson disease: Assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality (2015) AJNR am J Neuroradiol.
Reiter, E., Mueller, C., Pinter, B., Krismer, F., Scherfler, C., Esterhammer, R., Kremser, C., Seppi, K., Dorsolateral nigral hyperintensity on 3.0 T susceptibility-weighted imaging in neurodegenerative Parkinsonism (2015) Mov Disord, 30 (8), pp. 1068-1076
Ohtsuka, C., Sasaki, M., Konno, K., Koide, M., Kato, K., Takahashi, J., Takahashi, S., Terayama, Y., Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson’s disease using neuromelanin-sensitive MR imaging (2013) Neurosci Lett, 541, pp. 93-98
Davie, C.A., Wenning, G.K., Barker, G.J., Tofts, P.S., Kendall, B.E., Quinn, N., Mc Donald, W.I., Miller, D.H., Differentiation of multiple system atrophy from idiopathic Parkinson’s disease using proton magnetic resonance spectroscopy (1995) Ann Neurol, 37 (2), pp. 204-210
Cruz, C.J., Aminoff, M.J., Meyerhoff, D.J., Graham, S.H., Weiner, M.W., Proton MR spectroscopic imaging of the striatum in Parkinson’s disease (1997) Magn Reson Imaging, 15 (6), pp. 619-624
Tedeschi, G., Litvan, I., Bonavita, S., Bertolino, A., Lundbom, N., Patronas, N.J., Hallett, M., Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson’s disease and corti-cobasal degeneration (1997) Brain, 120, pp. 1541-1552
Clarke, C.E., Lowry, M., Horsman, A., Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson’s disease measured by proton magnetic resonance spectroscopy (1997) Mov Disord, 12 (3), pp. 297-301
Taylor-Robinson, S.D., Turjanski, N., Bhattacharya, S., Seery, J.P., Sargentoni, J., Brooks, D.J., Bryant, D.J., Cox, I.J., A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson’s disease (1999) Metab Brain Dis, 14 (1), pp. 45-55
Hu, M.T., Taylor-Robinson, S.D., Chaudhuri, K.R., Bell, J.D., Morris, R.G., Clough, C., Brooks, D.J., Turjanski, N., Evidence for cortical dysfunction in clinically non-demented patients with Parkinson’s disease: A proton MR spectroscopy study (1999) J Neurol Neurosurg Psychiatry, 67 (1), pp. 20-26
Lucetti, C., Del Dotto, P., Gambaccini, G., Bernardini, S., Bianchi, M.C., Tosetti, M., Bonuccelli, U., Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson’s disease patients (2001) Neurol Sci, 22 (1), pp. 69-70
Camicioli, R.M., Korzan, J.R., Foster, S.L., Fisher, N.J., Emery, D.J., Bastos, A.C., Hanstock, C.C., Posterior cingulate metabolic changes occur in Parkinson’s disease patients without dementia (2004) Neurosci Lett, 354 (3), pp. 177-180
Camicioli, R.M., Hanstock, C.C., Bouchard, T.P., Gee, M., Fisher, N.J., Martin, W.R., Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson’s disease (2007) Mov Disord, 22 (3), pp. 382-386
Guevara, C.A., Blain, C.R., Stahl, D., Lythgoe, D.J., Leigh, P.N., Barker, G.J., Uantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy (2010) Eur J Neurol, 17 (9), pp. 1193-1202
Federico, F., Simone, I.L., Lucivero, V., Mezzapesa, D.M., De Mari, M., Lamberti, P., Petruzzellis, M., Ferrari, E., Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes (1999) Ital J Neurol Sci, 20 (4), pp. 223-229
Watanabe, H., Fukatsu, H., Katsuno, M., Sugiura, M., Hamada, K., Okada, Y., Hirayama, M., Sobue, G., Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker (2004) J Neurol Neurosurg Psychiatry, 75 (1), pp. 103-109
Griffith, H.R., Okonkwo, O.C., O’brien, T., Hollander, J.A., Reduced brain glutamate in patients with Parkinson’s disease (2008) NMR Biomed, 21 (4), pp. 381-387
Kickler, N., Krack, P., Fraix, V., Lebas, J.F., Lamalle, L., Durif, F., Krainik, A., Pollak, P., Glutamate measurement in Parkinson’s disease using MRS at 3 T field strength (2007) NMR Biomed, 20 (8), pp. 757-762
Oz, G., Terpstra, M., Tkac, I., Aia, P., Lowary, J., Tuite, P.J., Gruetter, R., Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations (2006) Magn Reson Med, 55 (2), pp. 296-301
Emir, U.E., Tuite, P.J., Oz, G., Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS (2012) Plos One, 7 (1), pp. e30918
Morgen, K., Sammer, G., Weber, L., Aslan, B., Muller, C., Bachmann, G.F., Sandmann, D., Reuter, I., Structural brain abnormalities in patients with Parkinson disease: A comparative voxel-based analysis using T1-weighted MR imaging and magnetization transfer imaging (2011) AJNR am J Neuroradiol, 32 (11), pp. 2080-2086
Tambasco, N., Belcastro, V., Sarchielli, P., Floridi, P., Pierguidi, L., Menichetti, C., Castrioto, A., Rossi, A., A magnetization transfer study of mild and advanced Parkinson’s disease (2011) Eur J Neurol, 18 (3), pp. 471-477
Eckert, T., Sailer, M., Kaufmann, J., Schrader, C., Peschel, T., Bodammer, N., Heinze, H.J., Schoenfeld, M.A., Differentiation of idiopathic Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging (2004) Neuroimage, 21 (1), pp. 229-235
Quattrone, A., Nicoletti, G., Messina, D., Fera, F., Condino, F., Pugliese, P., Lanza, P., Gallo, O., MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy (2008) Radiology, 246 (1), pp. 214-221
Morelli, M., Arabia, G., Messina, D., Vescio, B., Salsone, M., Chiriaco, C., Perrotta, P., Quattrone, A., Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson’s disease (2014) Mov Disord, 29 (4), pp. 488-495
Paviour, D.C., Price, S.L., Jahanshahi, M., Lees, A.J., Fox, N.C., Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radio-logical correlations (2006) Mov Disord, 21 (7), pp. 989-996
Kashihara, K., Shinya, T., Higaki, F., Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease (2011) J Clin Neurosci, 18 (8), pp. 1093-1096
Ziegler, D.A., Wonderlick, J.S., Ashourian, P., Hansen, L.A., Young, J.C., Murphy, A.J., Koppuzha, C.K., Corkin, S., Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease (2013) JAMA Neurol, 70 (2), pp. 241-247
Jesse, S., Kassubek, J., Muller, H.P., Ludolph, A.C., Unrath, A., Signal alterations of the basal ganglia in the differential diagnosis of Parkinson’s disease: A retrospective case-controlled MRI data bank analysis (2012) BMC Neurol, 12, p. 163
Groschel, K., Hauser, T.K., Luft, A., Patronas, N., Dichgans, J., Litvan, I., Schulz, J.B., Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from cortico-basal degeneration (2004) Neuroimage, 21 (2), pp. 714-724
Josephs, K.A., Tang-Wai, D.F., Edland, S.D., Knopman, D.S., Dickson, D.W., Parisi, J.E., Petersen, R.C., Boeve, B.F., Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration (2004) Arch Neurol, 61 (12), pp. 1881-1884
Pereira, J.B., Ibarretxe-Bilbao, N., Marti, M.J., Compta, Y., Junque, C., Bargallo, N., Tolosa, E., Assessment of cortical degeneration in patients with Parkinson’s disease by voxel-based morphometry, cortical folding, and cortical thickness (2012) Hum Brain Mapp, 33 (11), pp. 2521-2534
Beyer, M.K., Janvin, C.C., Larsen, J.P., Aarsland, D., A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry (2007) J Neurol Neurosurg Psychiatry, 78 (3), pp. 254-259
Biundo, R., Formento-Dojot, P., Facchini, S., Vallelunga, A., Ghezzo, L., Foscolo, L., Meneghello, F., Antonini, A., Brain volume changes in Parkinson’s disease and their relationship with cognitive and behavioural abnormalities (2011) J Neurol Sci, 310 (1-2), pp. 64-69
Ramirez-Ruiz, B., Marti, M.J., Tolosa, E., Bartres-Faz, D., Summerfield, C., Salgado-Pineda, P., Gomez-Anson, B., Junque, C., Longitudinal evaluation of cerebral morphological changes in Parkinson’s disease with and without dementia (2005) J Neurol, 252 (11), pp. 1345-1352
Yang, J., Shao, N., Li, J., Shang, H., Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy (2014) Neurol Sci, 35 (1), pp. 7-14
Minnerop, M., Specht, K., Ruhlmann, J., Schimke, N., Abele, M., Weyer, A., Wullner, U., Klockgether, T., Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters (2007) Neuroimage, 36 (4), pp. 1086-1095
Shigemoto, Y., Matsuda, H., Kamiya, K., Maikusa, N., Nakata, Y., Ito, K., Ota, M., Sato, N., In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM (2013) Neuroimage Clin, 2, pp. 491-496
Brenneis, C., Boesch, S.M., Egger, K.E., Seppi, K., Scherfler, C., Schocke, M., Wenning, G.K., Poewe, W., Cortical atrophy in the cerebellar variant of multiple system atrophy: A voxel-based morphometry study (2006) Mov Disord, 21 (2), pp. 159-165
Boxer, A.L., Geschwind, M.D., Belfor, N., Gorno-Tempini, M.L., Schauer, G.F., Miller, B.L., Weiner, M.W., Rosen, H.J., Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy (2006) Arch Neurol, 63 (1), pp. 81-86
Focke, N.K., Helms, G., Scheewe, S., Pantel, P.M., Bachmann, C.G., Dechent, P., Ebentheuer, J., Trenkwalder, C., Individual voxelbased subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls (2011) Hum Brain Mapp, 32 (11), pp. 1905-1915
Singh, G., Samavedham, L., Unsupervised learning based feature extraction for differential diagnosis of neurodegenerative diseases: A case study on early-stage diagnosis of Parkinson disease (2015) J Neurosci Methods, 256, pp. 30-40
Kikuchi, A., Takeda, A., Okamura, N., Tashiro, M., Hasegawa, T., Furumoto, S., Kobayashi, M., Itoyama, Y., In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl) ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy (2010) Brain, 133, pp. 1772-1778. , awq091 [pii]
Movement disorders: Focus on Parkinson’s disease and related disorders
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(297 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(292 views) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote